Articles By Anuja Singh
Is Optic and Mechanica’s AI Venture Model the Future of Biotech Creation? Strategic Expansion…
Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…
By
Is the OBI Pharma–TegMine Therapeutics ADC Deal the Next Leap in Precision Oncology Using…
Key Highlights 1. Powering the Next-Gen ADC Revolution: OBI’s GlycOBI® Meets TegMine’s TegMiner™The collaboration between Taiwan-based OBI Pharma…
Can AI Reveal the Hidden Biology of Cancer? Aitia and Gustave Roussy Join Forces…
Key Highlights: AI Collaboration to Decode Cancer ComplexityIn a bold step to redefine cancer treatment, Aitia, a leader…
Is Juvenescence’s Acquisition of Ro5 the Key to Unlocking AI-Driven Longevity Therapies in 2025?
Key Insights Juvenescence Acquires Ro5 to Bolster AI Capabilities in Drug DiscoveryJuvenescence Limited, a clinical-stage AI-enabled biotech company,…
Can AI Turn Biobank Data into Precision Drug Discovery Gold? Inside the Elucidata–Sapien Biosciences…
Key Highlights Transforming Biobanks into AI-Driven EnginesElucidata, a U.S.-India based AI pioneer in life sciences, and Sapien Biosciences,…
How Will Axxam and Molecular Health’s AI-Powered Alliance Accelerate Target Discovery and De-Risk Drug…
Key Highlights: Strategic Collaboration Targets Early Drug Discovery BottlenecksAnnounced on June 4, 2025, Molecular Health and Axxam have…
Is Optic and Mechanica’s AI Venture Model the Future of Biotech Creation? Strategic Expansion…
Key Highlights Strategic Collaboration to Power AI-Led Biotech GrowthOptic, Inc., a pioneer in AI platforms for biopharma, has…
Is the OBI Pharma–TegMine Therapeutics ADC Deal the Next Leap in Precision Oncology Using…
Key Highlights 1. Powering the Next-Gen ADC Revolution: OBI’s GlycOBI® Meets TegMine’s TegMiner™The collaboration between Taiwan-based OBI Pharma…
Can AI Reveal the Hidden Biology of Cancer? Aitia and Gustave Roussy Join Forces…
Key Highlights: AI Collaboration to Decode Cancer ComplexityIn a bold step to redefine cancer treatment, Aitia, a leader…
Is Juvenescence’s Acquisition of Ro5 the Key to Unlocking AI-Driven Longevity Therapies in 2025?
Key Insights Juvenescence Acquires Ro5 to Bolster AI Capabilities in Drug DiscoveryJuvenescence Limited, a clinical-stage AI-enabled biotech company,…
Can AI Turn Biobank Data into Precision Drug Discovery Gold? Inside the Elucidata–Sapien Biosciences…
Key Highlights Transforming Biobanks into AI-Driven EnginesElucidata, a U.S.-India based AI pioneer in life sciences, and Sapien Biosciences,…
How Will Axxam and Molecular Health’s AI-Powered Alliance Accelerate Target Discovery and De-Risk Drug…
Key Highlights: Strategic Collaboration Targets Early Drug Discovery BottlenecksAnnounced on June 4, 2025, Molecular Health and Axxam have…